TY - JOUR
T1 - Stepwise treatment of uncontrolled HyperTensioN (Stepwise-HTN)
T2 - Study design of a cluster randomised controlled trial in primary care
AU - Kiliç, Birsen
AU - Biermans, Marion C.J.
AU - Rutten, Frans H.
AU - Deinum, Jaap
AU - Spiering, Wilko
AU - van der Wel, Mark C.
AU - de Grauw, Wim J.C.
AU - Bots, Michiel L.
AU - Hollander, Monika
N1 - Funding Information:
The medical Ethics Committee of the University Medical Center (UMC) Utrecht approved the study (NL61553.041.17).
Funding Information:
The study is conducted with an unrestricted research grant from The Netherlands Organization for Health Research and Development (ZonMw, project number: 839110013) and an additional grant from the Dutch Kidney foundation (project code: KF3P0lA).
Publisher Copyright:
© 2023 The Authors
PY - 2023/3
Y1 - 2023/3
N2 - Background: Uncontrolled hypertension is a major health problem, and a key risk factor for cardiovascular disease. Most patients are detected and managed in primary care, but approximately 50% remains uncontrolled. Our aim is to assess whether a guided stepwise work-up management strategy for patients with uncontrolled hypertension in primary care would result in better blood pressure control in these patients compared to usual care. Methods: A cluster randomised controlled trial aiming at randomizing 40 general practices to either “a protocolised stepwise work-up” or to “usual care”. Uncontrolled hypertension is defined as an office blood pressure (BP) >140/90 mmHg while being prescribed three or more antihypertensive drugs simultaneously from different therapeutic classes for three or more months in an adequate dose. In the intervention arm, patients with uncontrolled hypertension will receive the stepwise approach, consisting of (i) excluding a white coat effect, (ii) re-evaluation of lifestyle, (iii) re-evaluation of drug adherence, (iv) optimalisation of antihypertensive treatment and (v) referral if the office BP is still >140/90 mmHg. The control group receives usual care in a regular program for cardiovascular risk management. The primary outcome is the absolute difference in the mean 24-h systolic BP between intervention and control arm after 8 months. Secondary outcomes include differences in the percentage of patients achieving a controlled BP, and time to reach a controlled BP. Conclusion: If stepwise treatment of uncontrolled hypertension is proven effective, the strategy could be implemented by blending the approach to the cardiovascular risk management already applied in general practice. Trial registration NTR7304, https://www.trialregister.nl/trial/7099
AB - Background: Uncontrolled hypertension is a major health problem, and a key risk factor for cardiovascular disease. Most patients are detected and managed in primary care, but approximately 50% remains uncontrolled. Our aim is to assess whether a guided stepwise work-up management strategy for patients with uncontrolled hypertension in primary care would result in better blood pressure control in these patients compared to usual care. Methods: A cluster randomised controlled trial aiming at randomizing 40 general practices to either “a protocolised stepwise work-up” or to “usual care”. Uncontrolled hypertension is defined as an office blood pressure (BP) >140/90 mmHg while being prescribed three or more antihypertensive drugs simultaneously from different therapeutic classes for three or more months in an adequate dose. In the intervention arm, patients with uncontrolled hypertension will receive the stepwise approach, consisting of (i) excluding a white coat effect, (ii) re-evaluation of lifestyle, (iii) re-evaluation of drug adherence, (iv) optimalisation of antihypertensive treatment and (v) referral if the office BP is still >140/90 mmHg. The control group receives usual care in a regular program for cardiovascular risk management. The primary outcome is the absolute difference in the mean 24-h systolic BP between intervention and control arm after 8 months. Secondary outcomes include differences in the percentage of patients achieving a controlled BP, and time to reach a controlled BP. Conclusion: If stepwise treatment of uncontrolled hypertension is proven effective, the strategy could be implemented by blending the approach to the cardiovascular risk management already applied in general practice. Trial registration NTR7304, https://www.trialregister.nl/trial/7099
KW - Cluster randomised controlled trial
KW - General practice
KW - Uncontrolled hypertension
UR - http://www.scopus.com/inward/record.url?scp=85147384900&partnerID=8YFLogxK
U2 - 10.1016/j.cct.2022.107062
DO - 10.1016/j.cct.2022.107062
M3 - Article
C2 - 36632924
AN - SCOPUS:85147384900
SN - 1551-7144
VL - 126
JO - Contemporary Clinical Trials
JF - Contemporary Clinical Trials
M1 - 107062
ER -